Skip to content

HHS Finalizes Major HIPAA Privacy Rule Changes: What Healthcare Organizations Need to Know

November 17, 2026

On November 16, 2026, the U.S. Department of Health and Human Services (“HHS”) Office for Civil Rights (“OCR”) announced a final rule amending the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) Privacy Rule. The rule, titled HIPAA Privacy Rule: Changes to Support Coordinated Care and Individual Engagement and Reduce Regulatory Burdens (“Final Rule”), strengthens individuals’ rights to access protected health information (“PHI”), facilitates care coordination, and eliminates certain administrative requirements.

For covered healthcare providers and health plans, the amendments present a mix of relief and new compliance work, particularly for medical records operations, health information management systems (HIMS), electronic access, patient notices, and third-party service arrangements.

1. Shorter Deadline for Patient Access Requests

Covered entities must act on an individual’s access request as soon as practicable, but no later than 15 calendar days after receipt, rather than the current 30 days. One extension of up to 30 additional calendar days remains available when necessary, provided the individual receives written notice within the initial 15 days explaining the delay and specifying the completion date.

If another applicable federal or state law requires access sooner, that shorter period controls. The 15-day deadline is an outer limit, not a default processing period; other applicable information-blocking requirements may also call for faster action.

Providers and health plans should assess whether medical records teams, HIMS, and release-of-information vendors can meet the shorter timeline, including for records held in multiple systems or by business associates. Covered entities remain responsible for access when a business associate holds the requested PHI. A business associate may provide records directly to an individual or designee if the agreement permits or requires it; otherwise, it must make the information available to the covered entity. When an agreement assigns direct response responsibility to a business associate, the 15-day clock can begin when the associate receives the request. Organizations will need to align contracts, intake procedures, tracking, and escalation accordingly.

2. Access Through Personal Health Applications

The Final Rule clarifies that an individual may obtain electronic PHI (“ePHI”) through a personal health application when the requested form and format are readily producible by the covered entity. Where applicable federal or state law requires access in a particular electronic format, that format is deemed readily producible for HIPAA purposes. The rule defines a personal health application by reference to information managed, shared, or controlled by or primarily for the individual, rather than by or primarily for a regulated entity or another person.

That distinction matters. An independent, patient-controlled app generally is not a HIPAA business associate merely because it receives information at the patient’s direction. By contrast, an app operated for a covered entity may involve a business associate relationship and remains subject to the applicable HIPAA framework. Once information reaches an independent app outside HIPAA, the app’s handling of the information may be governed by other laws and the app developer’s own practices.

Covered entities ordinarily may not refuse an otherwise valid access request solely because they question an independent app’s downstream privacy practices. They may, however, consider genuine risks to their own systems when determining whether a requested transmission method is readily producible. Organizations should review patient-facing technology to determine potential technical limitations and update any notices explaining third-party app risks without creating barriers to access. It is important to note that a request to transfer ePHI to a personal health application is subject to the same 15-day access deadline and permitted extension. This will make it even more important that a covered entity understands its system’s capabilities and limitations beforehand so it can respond promptly.

3. Revised Access Fees and Fee Transparency

The Final Rule prohibits fees for inspecting PHI and for obtaining ePHI through qualifying internet-based methods, such as self-service access through a patient portal or personal health application. The no-fee rule does not necessarily cover every electronic delivery method; for example, generating and emailing a requested PDF may involve allowable copying labor.

Where fees remain permissible, the rule limits charges for access requests to specified reasonable, cost-based expenses, including applicable copying labor, supplies for non-electronic copies, postage, and preparation of an agreed-upon summary or explanation. Different rules may govern disclosures made pursuant to a valid HIPAA authorization rather than an individual’s access right.

Covered entities must post an understandable fee schedule on their websites, if they have one, and make it available at the point of service and upon request. The schedule must identify free access options and standard fees for access requests, qualifying directed transmissions, and authorized disclosures. HHS did not finalize the proposed requirement to provide individualized fee estimates or itemized statements on request.

Organizations should review charges imposed by their records’ vendors and ensure that published schedules reflect how fees are actually calculated.

4. Right to Direct Electronic Records to Another Person

Implementing the HITECH Act and addressing the decision in Ciox Health, LLC v. Azar, the Final Rule confirms an individual’s right to direct a covered entity to send an electronic copy of PHI to a designated person. This right applies to information that is both maintained in an electronic health record and included in a designated record set; it does not extend to all records held electronically or to paper-only records.

A directive must be clear, conspicuous, and specific. A covered entity may require it in writing, but an electronic submission can satisfy that requirement. A qualifying directive does not require a separate HIPAA authorization and is subject to the same 15-day access deadline and permitted extension.

Requests outside the directive’s scope may be addressed through the individual’s own access rights, another permitted disclosure pathway, or a valid HIPAA authorization, as appropriate. Records personnel should distinguish among these requests rather than treating every third-party request alike.

5. Less Burdensome Identity Verification

Covered entities must continue to verify a requestor’s identity and authority where required, but may not impose unreasonable verification measures that obstruct access. Depending on the circumstances, requiring in-person verification, notarization, or a handwritten signature when a reasonable alternative is available may be impermissibly burdensome.

The rule does not mandate a single verification technology or prevent organizations from using safeguards proportionate to the risks. Access forms and procedures should be clearly communicated to individuals and permit reasonable electronic and remote verification while protecting against misdirected disclosures.

6. More Flexibility for Care Coordination

The Final Rule clarifies that health plans may use and disclose PHI for population-based and individual-level care coordination and case management as healthcare operations. It also expressly permits covered entities to disclose PHI to certain third parties providing health-related support to individuals, including social services agencies, community-based organizations, and home- and community-based services providers.

For example, the changes may facilitate coordination with organizations assisting patients with transportation, nutrition, or housing needs. This flexibility is especially relevant to federally qualified health centers, rural health clinics, critical access hospitals, health systems, health plans, and other organizations addressing health-related social needs.

The permission is not unlimited. Disclosures must fit the applicable treatment or healthcare operations provisions; the minimum-necessary standard continues to apply where required, including to healthcare operations disclosures, though it generally does not apply to disclosures to providers for treatment. Other applicable confidentiality protections, including state law and 42 CFR Part 2 where relevant, remain important. Whether a recipient needs a business associate agreement depends on the services performed and the relationship—not merely on receipt of PHI.

7. Notice of Privacy Practices Changes

Covered healthcare providers with direct treatment relationships no longer must make a good-faith effort to obtain written acknowledgment that patients received their Notice of Privacy Practices (“NPP”). Providers must still furnish the notice as required.

The Final Rule also revises NPP content to better explain individual access rights, available methods of obtaining PHI, and associated fees, and establishes a right to discuss the notice with a designated contact person or office. In addition, it removes the existing exception for inmates of correctional institutions to receive an NPP.

Covered entities should update NPP templates and related patient-facing materials, rather than merely removing acknowledgment forms.

8. Proposals Not Adopted

HHS did not adopt every provision of its 2021 proposal. Notably, it declined to create a new minimum-necessary exception for individual-level care coordination, mandate certain provider-to-provider requests at patients’ direction, or broadly replace professional-judgment standards with a good-faith standard. Organizations should base implementation on the final regulatory text, not earlier summaries of the proposal.

9. Effective Date and Compliance Timeline

The Final Rule will take effect on January 18, 2027. Covered entities and business associates generally must comply by July 17, 2027.

A limited transition provision allows additional time to update certain qualifying existing business associate agreements. That contractual accommodation does not extend the general deadline for complying with the rule’s substantive requirements. Organizations should review eligibility before relying on the transition period.

10. Recommended Compliance Priorities

Healthcare organizations should prioritize the following before the July 2027 compliance deadline:

  • Update access procedures: Shorten response timelines, clarify extension notices, and confirm responsibilities with and capabilities or release-of-information vendors and business associates.
  • Test electronic access: Review EHR, portal, and app capabilities, including readily producible formats and secure transmission methods.
  • Review fees and notices: Revise permissible charges and public fee schedules; update NPPs, forms, and verification procedures.
  • Reassess information sharing: Confirm legal bases, minimum-necessary obligations where applicable, and contractual responsibilities for care coordination arrangements.
  • Train affected personnel: Focus on records staff, privacy teams, patient-facing employees, and information technology personnel.

This publication is intended for general informational purposes only and does not constitute legal advice or a solicitation to provide legal services.  The information in this publication is not intended to create, and receipt of it does not constitute, a lawyer-client relationship.  Readers should not act upon this information without seeking professional legal counsel.  The views and opinions expressed herein represent those of the individual author only and are not necessarily the views of Clark Hill PLC.  Although we attempt to ensure that postings on our website are complete, accurate, and up to date, we assume no responsibility for their completeness, accuracy, or timeliness. 

Subscribe for the latest

Subscribe